Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1978 Apr 1;147(4):963–972. doi: 10.1084/jem.147.4.963

Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation

PMCID: PMC2184246  PMID: 25942

Abstract

Bone marrow (BM) and skin allografts from C57BL/Ka (H-2b/b) mice were transplanted to BALB/c (H-2d/d) recipients treated with total lymphoid irradiation (TLI), whole-body irradiation (WBI), or fractionated thymic irradiation TLI prolonged skin allograft survival about five times as long as that in untreated controls, and allowed for permanent engraftment of BM cells in approximately equal to 90% of recipients. None of the BM recipients showed clinical signs of graft-versus-host disease (GVHD) (diarrhea, weight loss, hunched back, etc.). On the other hand, recipients given WBI and allogeneic BM cells developed severe clinical GVHD. The majority of the latter recipients died within 12 days after BM transplantation, and 95% died within 61 days. Although TLI protected BALB/c mice against GVHD induced by BM cells, all recipients given TLI and allogeneic spleen cells developed lethal GVHD. Thymic irradiation alone marginally prolonged skin allograft survival, and did not allow for allogeneic BM engraftment. These results suggest that TLI may be a useful regimen in clinical BM transplantation, since this form of radiotherapy is used extensively in humans and has few severe side effects.

Full Text

The Full Text of this article is available as a PDF (649.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Klein J. Allograft reaction against H-2-region antigens. Transplant Proc. 1977 Mar;9(1):847–852. [PubMed] [Google Scholar]
  2. Lukes R. J., Tindle B. H. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med. 1975 Jan 2;292(1):1–8. doi: 10.1056/NEJM197501022920101. [DOI] [PubMed] [Google Scholar]
  3. Müller-Ruchholtz W., Wottge H. U., Müller-Hermelink H. K. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow. Transplant Proc. 1976 Dec;8(4):537–541. [PubMed] [Google Scholar]
  4. Rodt H., Thierfelder S., Eulitz M. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice. Eur J Immunol. 1974 Jan;4(1):15–19. doi: 10.1002/eji.1830040107. [DOI] [PubMed] [Google Scholar]
  5. Roos D., Loos J. A. Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim Biophys Acta. 1970 Dec 29;222(3):565–582. doi: 10.1016/0304-4165(70)90182-0. [DOI] [PubMed] [Google Scholar]
  6. Slavin S., Strober S., Fuks Z., Kaplan H. S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med. 1977 Jul 1;146(1):34–48. doi: 10.1084/jem.146.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Slavin S., Strober S., Fuks Z., Kaplan H. S. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science. 1976 Sep 24;193(4259):1252–1254. doi: 10.1126/science.785599. [DOI] [PubMed] [Google Scholar]
  8. Slavin S., Strober S., Fuks Z., Kaplan H. S. Use of total lymphoid irradiation in tissue transplantation in mice. Transplant Proc. 1977 Mar;9(1):1001–1004. [PubMed] [Google Scholar]
  9. Storb R., Kolb H. J., Graham T. C., Leblond R., Kolb H., Lerner K. G., Thomas E. D. Marrow grafts between histoincompatible canine family members. Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):680–685. [PubMed] [Google Scholar]
  10. von Boehmer H., Sprent J., Nabholz M. Hemopoietic reconstitution obtained in F1 hybrids by grafting of parental marrow cells. Transplant Proc. 1976 Sep;8(3):355–358. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES